In vitro α–amylase inhibitory activity and in vivo hypoglycemic effect of methanol extract of Citrus macroptera Montr. fruit  by Uddin, Nizam et al.
473
Document heading            doi:10.12980/APJTB.4.2014C1173                  襃 2014 by the Asian Pacific Journal of Tropical Biomedicine. All rights reserved.
In vitro α-amylase inhibitory activity and in vivo hypoglycemic effect of 
methanol extract of Citrus macroptera Montr. fruit
Nizam Uddin*, Md. Rakib Hasan, Md. Monir Hossain, Arjyabrata Sarker, A.H.M. Nazmul Hasan, A.F.M. Mahmudul Islam, 
Mohd. Motaher H. Chowdhury, Md. Sohel Rana
Laboratory of Natural Products Research, Department of Pharmacy, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh
Asian Pac J Trop Biomed 2014; 4(6): 473-479
Asian Pacific Journal of Tropical Biomedicine
journal homepage: www.apjtb.com
    *Corresponding author: Nizam Uddin, Laboratory of Natural Products Research, 
Department of Pharmacy, Jahangirnagar University, Savar, Dhaka-1342, Bangladesh. 
     Tel: +8801763148391
     E-mail: sami.pharm22@gmail.com
    Foundation Project: Supported by Laboratory of Natural Products Research, 
Jahangirnagar University, Dhaka, Bangladesh
1. Introduction
   Diabetes mellitus (DM) is a chronic metabolic 
disorder characterized by both postprandial and fasting 
hyperglycemia with disturbances in carbohydrate, fat and 
protein metabolism. Hyperglycemia in diabetes results 
either from an absolute deficiency in insulin secretion (type 
1 DM) or insulin action (type 2 DM) or both. The incidence 
of diabetes has increased worldwide in recent years. The 
estimated number of people with diabetes was 30 million 
in 1985, 150 million in 2000 and then 246 million in 2007, 
according to the International Diabetes Federation. It 
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Objective: To investigate the therapeutic effects of methanol extract of Citrus macroptera Montr.
fruit in α-amylase inhibitory activity (in vitro) and hypoglycemic activity in normal and glucose 
induced hyperglycemic rats (in vivo). 
Methods: Fruits of Citrus macroptera without rind was extracted with pure methanol following 
cold extraction and tested for presence of phytochemical constituents, α-amylase inhibitory 
activity, and hypoglycemic effect in normal rats and glucose induced hyperglycemic rats. 
Results: Presence of saponin, steroid and terpenoid were identified in the extract. The results 
showed that fruit extract had moderate α-amylase inhibitory activity [IC50 value=(3.638依0.190) 
mg/mL] as compared to acarbose. Moreover at 500 mg/kg and 1 000 mg/kg doses fruit extract 
significantly (P<0.05 and P<0.01 respectively) reduced fasting blood glucose level in normal 
rats as compared to glibenclamide (5 mg/kg). In oral glucose tolerance test, 500 mg/kg dose 
significantly reduced blood glucose level (P<0.05) at 2 h but 1 000 mg/kg dose significantly reduced 
blood glucose level at 2 h and 3 h (P<0.05 and P<0.01 respectively) whereas glibenclamide (5 mg/
kg) significantly reduced glucose level at every hour after administration. Overall time effect 
is also considered extremely significant with F value=23.83 and P value=0.0001 in oral glucose 
tolerance test. 
Conclusion: These findings suggest that the plant may be a potential source for the development 
of new oral hypoglycemic agent.
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piece of work where hypoglycemic 
effect of a fruit extract from Citrus 
macroptera observed and this is a 
unique work of this fruit in the world 
as far as I know. Author coherently 
discussed therapeutic properties of 
phytochemical constituents to support 
the hypoglycemic potential of the 
fruit extract. α-Amylase inhibition 
property and OGTT was performed 
for this research and the result was 
significant; also there was a set up of 
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expects this number to hit 380 million by 2025[1].
   Treatment of diabetes include: enhancement of the 
action of insulin at the target tissues, with the use of 
sensitizers (biguanides, thiozolidinediones); stimulation of 
endogenous insulin secretion with the use of sulfonylureas 
(glibenclamide, glimepiride), and reduction of the demand 
for insulin using specific enzyme inhibitors (acarbose, 
miglitol)[2]. However, there is a burden of unwanted side 
effects like diarrhea, nausea, dyspepsia, myocardial 
infarction, peripheral edema and dizziness with the use of 
these drugs. Plants have been an exemplary source of drugs 
that have been derived directly or indirectly from them. It 
is reported that about 800 plants may possess anti-diabetic 
potential[3]. Hypoglycemic activity of medicinal plants is due 
to their ability to restore the function of pancreatic tissues 
by causing an increase in insulin output, inhibiting the 
intestinal absorption of glucose or facilitating metabolites in 
insulin dependent processes[4,5].
   Citrus macroptera Montr. (family-Rutaceae) (C. 
macroptera) commonly called Sat Kara (wild orange), 
is a semi-wild species of Citrus native in Malesia and 
Melanesia. The tree, which has thorns, can reach 5 m 
in height. Its fruit is about 6-7 cm in diameter, has a 
fairly smooth, moderately thick rind, and turns yellow 
when it is ripe. The pulp of the fruit is greenish yellow 
and dry (does not produce much juice). The juice is very 
sour, and somewhat bitter. In Bangladesh the rind of 
the C. macroptera is eaten as a vegetable. This plant is 
medicinally used locally in Assam. Physicians always 
suggest diabetic patient to eat Citrus fruits to control their 
blood glucose level. Researchers also concluded that 
Citrus fruit extracts represent an excellent alternative for 
nutraceuticals and functional foods geared towards the 
management of diabetes. Essential oil of fruit of Citrus 
maximally showed significant reduction of fasting blood 
glucose and hepatic glucose levels while hepatic glycogen 
significantly increased when compared to diabetic control 
animals[6]. According to a 2006 animal study, Citrus 
extracts not only slow glucose uptake, but also inhibit the 
movement or transport of glucose through the intestines 
and liver[7]. A 2009 study examining extracts from a Korean 
Citrus fruit called Dangyuja (Citrus grandis) found that it 
holds great potential for controlling blood glucose levels in 
diabetic patients[8]. Citrus limetta fruit peel demonstrated 
a potential anti-hyperglycemic effect in streptozotocin 
induced diabetic rats[9]. There are also many other 
research reports about this therapeutic effect of Citrus 
fruits. Investigation on C. macroptera for hypoglycemic 
property has not been performed yet. That’s why we have 
designed our research work to explore possible mechanism 
of hypoglycemic activity of this fruit extract. 
2. Materials and methods
2.1. Drugs, chemicals and apparatus
   Methanol was bought from SIGMA® (Sigma-Aldrich®, St 
Louis, USA), while acarbose tablet was purchased from local 
market, manufactured by Pacific Pharmaceuticals Ltd., 
Bangladesh. Starch was purchased from local scientific 
market, Motijheel, Dhaka. Heparin injection was purchased 
from Rotex Medica, Germany. Amylase was obtained from 
Merck, Germany. All the chemicals and reagents were 
analytical grade. Match® glucometer with strips were 
purchased from Mohammadpur, Dhaka. Humalyzer 3500 was 
obtained from Human Inc., Germany.
2.2. Plant material
   Fruits of C. macroptera were collected from Sylhet, 
Bangladesh and authenticated by Md. Abdur Rahim, 
Technical officer, Department of Botany, Jahangirnagar 
University. A voucher specimen (Acc. No. 38619) was 
deposited in the herbarium for future reference. The peels 
were removed and the fruits were dried and used for further 
processing.
2.3. Preparation of plant extract
   Fruits without rind were treated with sufficient amount 
of pure methanol for one week at room temperature with 
occasional shaking. The extract was filtered through a cotton 
plug followed by Whatman No. 1 filter paper. The filtrate was 
then evaporated under reduced pressure to give a dark green 
viscous mass and stored at 4 °C until use.
2.4. Animals and experimental set-up
   Sprague-Dawley female rats of 100-200 g were collected 
from Pharmacology Laboratory, Department of Pharmacy, 
Jahangirnagar University and were acclimatized to normal 
laboratory conditions for one week prior to study and were 
assessed to pellet diet and water ad libitum. Temperature of 
facility was (22依3) °C and light/darkness alternated 12 h apart. 
The animals were divided into four groups of five animals 
each.
2.5. Phytochemical screening 
   The crude methanol extract of C. macroptera fruits 
underwent phytochemical screening to detect presence of 
potential phytochemical constituents like alkaloid, flavonoid, 
saponin, tannin, carbohydrate, glycoside, glucoside, fat and 
fixed oil, steroid and terpenoid[10].
Nizam Uddin et al./Asian Pac J Trop Biomed 2014; 4(6): 473-479 475
2.6. In vitro α-amylase inhibitory activity
   This study was performed by a modified starch iodine 
protocol[11]. In short, 1 mL of plant extract or standard of 
different concentration (2, 1, 0.5 mg/mL) was taken in pre-
labeled test tubes. A volume of 20 µL of α-amylase was 
added to each test tube and incubated for 10 min at 37 °C. 
After the incubation 200 µL of 1% starch solution was added 
to each test tube and the mixture was re-incubated for 1 h at 
37 °C. Then 200 µL of 1% iodine solution was added to each 
test tube and after that, 10 mL distilled water was added. 
Absorbance of the mixture was taken at 565 nm. Sample, 
substrate and α-amylase blank were undertaken under the 
same conditions. Each experiment was done in triplicate. 
IC50 value was calculated by using regression analysis.
% α-amylase inhibition= [1-
(SA-SBB)-SMB
AAB
] 伊100
   SA=Sample  absorbance ,  SMB=Sample  b lank, 
SBB=Substrate blank, AAB=α-Amylase blank
2.7. Acute toxicity study
   According to the method of Walum, et al. rats were divided 
into four groups of five animals each[12]. Different doses 
(1 000 mg/kg, 2 000 mg/kg, 3 000 mg/kg and 4 000 mg/kg) of 
methanol extracts were administered by stomach tube. Then 
the animals were observed for general toxicity signs.
2.8. Experimental protocol for in vivo hypoglycemic activity
2.8.1. Hypoglycemic effect in normal rats
   Rats were kept fasting overnight with free access to water. 
Group I was treated as control group, Group II was treated 
with glibenclamide (5 mg/kg body weight), Group III and 
IV was treated with 500 mg/kg and 1 000 mg/kg body weight 
respectively. Before administration of drug and extract 
solutions fasting blood glucose levels were estimated by 
glucose oxidase method[13]. Then blood glucose levels were 
again estimated after 2 h of administration of drug and 
extract solutions. Glucose levels were measured by blood 
Humalyzer instrument. The maximum hypoglycemic effect 
of glibenclamide was found after 2 h of its administration.
2.8.2. Hypoglycemic effect in glucose induced hyperglycemic 
rats (OGTT)
   Oral glucose tolerance test (OGTT) was performed according 
to the standard method[14]. Group I was treated as normal 
control group, Group II treated with glibenclamide (5 mg/
kg body weight), Group III and IV treated with 500 mg/kg 
and 1 000 mg/kg body weight respectively. Glucose solution 
(1 g/kg body weight) was administered at first. Then drug 
and extract solutions were administered to the glucose fed. 
Serum glucose level of blood sample from tail vein was 
estimated by using glucometer at 0, 1, 2 and 3 h.
2.9. Statistical analysis
   The results were expressed as the mean依SEM. The results 
were statistically analyzed using repeated measures 
analysis of variance with Dunnett’s multiple comparison 
when compared against control in OGTT. Paired t test was 
performed to show significant variation between before and 
after blood glucose level. Student’s t test was performed 
between IC50 values. Regression analysis was performed 
to calculate IC50 values. P<0.05, P<0.01 and P<0.001 were 
considered as statistically significant. Statistical programs 
used were GRAPHPAD PRISM® (version 6.00; GraphPad 
Software Inc., San Diego, CA, USA),  SIGMAPLOT  (version 12.0, 
Systat Software Inc., San Jose, California, USA), and Microsoft 
Excel, 2007.
3. Results
3.1. Phytochemical screening
   The active components found in the extract include; 
saponin, steroid and terpenoid. Results are shown in Table 
1.
Table1
Phytochemical constituents identified in methanol extract of 
C. macroptera  fruit.
Phytochemical  constituents Specific tests Result
Carbohydrate Molisch ’s test    -
Barfoed’s test    -
Benedict's test    -
Fehling  test    -
Glycoside General test    -
Bromine water  test    -
Glucoside General test    -
Fat and fixed oils Stain test    -
Saponification test    -
Alkaloid Mayer’s test    -
Hager’s test    -
Dragendorff’s  test    -
Wagner test    -
Tannic acid test    -
Tannin Lead acetate test     -
Ferric chloride test    -
Alkaline reagent test    -
Steroid Liebermann-Burchard’s test     +
Terpenoid Salkowski test     +
Saponin Frothing test    + +
Flavonoid General test     -
Shinoda test    +/-
+: Presence, -: Absence, +/-: Presence/absence not ascertained.
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3.2. In vitro α-amylase inhibitory activity
   Methanol extract showed IC50 value (3.638依0.190) mg/mL 
whereas standard acarbose showed (0.912依0.015) mg/mL. 
Methanol extract significantly inhibited α-amylase activity 
in a dose dependent manner like acarbose. Therefore we can 
conclude that this fruit extract have moderate α-amylase 
inhibitory activity. All results are shown in Table 2.
3.3. Acute toxicity study
   The extract administered up to high dose (4 000 mg/kg) 
produced no mortality. The animals did not manifest any 
sign of restlessness, respiratory distress, general irritation, 
coma or convulsion. Hence this extract was considered safe 
for rats.
Table 2
IC50 values  (mg/mL) for C. macroptera methanolic fruit extract and acarbose 
in α-amylase inhibitory assay.
Extract/
Standard
Concentrations in mg/mL with  ( % Inhibition )    
IC50 value 
 ( mg/mL)
Methanol extract 0.50 (8.974依0.256) 1.00 (13.846依0.444) 2.00 (28.718依1.282) 3.638依0.190b
Acarbose   0.25 (15.897依1.117) 0.50 (26.051依0.438) 1.00 (55.385依0.888) 0.912依 0.015a
Values are the mean of triplicate experiments and represented as mean依SEM 
(n=3). Values in the same column with different superscripts are significantly 
different (P<0.05). Student’s t test was performed to analyze this data set.
3.4. In vivo hypoglycemic activity
3.4.1. Hypoglycemic effect in normal rats
   Both doses of methanol extract and glibenclamide 
significantly reduced fasting blood glucose level. 
Glibenclamide showed significant reduction at level of 
P<0.01. Dose of 500 mg/kg and 1 000mg/kg methanolic fruit 
extract showed significant reduction at level of P<0.05 and 
P<0.01 respectively. These results suggest that hypoglycemic 
activity of 1 000 mg/kg dose and glibenclamide has similar 
significance level. All results are presented in Table 3.
Table 3
Effect of C. macroptera  methanolic fruit extract on fasting blood glucose level 
(mmol/L) in normal rats.
Group Dose (oral) Before administration After administration
Control 10 mL/kg 4.851依1.188a 5.764依0.668a
Glibenclamide 5 mg/kg 3.952依0.334a 2.016依0.113b
500 mg/kg 500 mg/kg 4.280依0.195a 3.473依0.102b
1000 mg/kg 1000 mg/kg 6.089依0.397a 4.055依0.317b
Values are presented in mean依SEM (n=4). Values in the same row with 
different superscripts are significantly different. For control (a, b) P>0.05, 
for glibenclamide (a, b) P<0.01, for Fruit-500 mg/kg (a, b) P<0.05 and for 
Fruit-1 000 mg/kg (a, b) P<0.01. Paired t test was performed to analyze this 
data set.
3.4.2. Hypoglycemic effect in glucose induced hyperglycemic 
rats (OGTT)
   Experimental induction of hyperglycemia resulted in 
increased glucose level in blood (comparing the bar diagram 
of control of 0 h and 1 hour, Figure 1). Both dose of fruit 
extract did not manifest any significant reduction in 1st hour 
after administration. Most significant reduction (P<0.05) was 
observed for 500 mg/kg dose of methanolic fruit extract at 
2 h but maximum reduction of 1 000 mg/kg dose occurred 
at 3 h showing a significance level of P<0.01. At 2 h this 
dose also showed significant reduction (P<0.05). Standard 
glibenclamide (5 mg/kg) showed significant reduction in 1, 
2 and 3 h. These findings suggest that evidently 1 000 mg/kg 
dose is more potent than 500 mg/kg dose. Time interaction 
with each specific hour in this experiment was also found 
extremely significant (P<0.000 1) with an F value 23.83 (Table 
4).
Table 4
Effect of C. macroptera methanolic fruit extract on glucose induced 
hyperglycemia (mmol/L) in normal rats.
Treatment 
groups
0 hour 1 hour 2 hour 3 hour
Time effect 
(F value)
P value for 
time effect
Control 6.850依0.222 7.850依0.569 7.150依0.272 6.475依0.175
F(3, 36)=23.83 P<0.000 1
Glibenclamide 6.950依0.301 6.250依0.589b 4.125依0.239c 4.275依0.476c
500 mg/kg 6.500依0.267 6.875依0.095 5.900依0.303a 5.500依0.450
1000 mg/kg 6.600依0.168 6.750依0.189 5.700依0.470a 4.675依0.459b
Values are presented in mean依SEM (n=4). Values with different superscripts 
in the same column are significantly different from control at each specific 
hour. a: P<0.05, b: P<0.01 and c: P<0.001. Overall time effect is considered 
extremely significant and its F and P value are given in the table. Repeated 
measures Anova with Dunnett’s multiple comparison were performed to 
analyze this data set.
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Figure 1. Effect of different doses of fruit extract of C. macroptera and 
glibenclamide on oral glucose tolerance test. Results are expressed as mean依
SEM. Values with different superscripts are significantly different from control. 
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4. Discussion
4.1. α-Amylase inhibitory activity
   α-Amylase is one of the main enzymes in human body that 
is responsible for the breakdown of starch to more simple 
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sugars. α-Amylases hydrolyze complex polysaccharides to 
produce oligosaccharides and disaccharides which are then 
hydrolyzed by α-glycosidase to monosaccharide which are 
absorbed through the small intestines into the hepatic portal 
vein and increase postprandial glucose levels[15,16]. Amylase 
inhibitors are also known as starch blockers because they 
prevent dietary starch from being absorbed by the body 
and thereby lower postprandial glucose levels. Slowing the 
digestion and breakdown of starch may have beneficial 
effects on insulin resistance and glycemic index control in 
people with diabetes[17-19]. In our investigation we found that 
methanolic fruit extract moderately inhibited α-amylase. 
From phytochemical screening we can see that presence of 
saponin, steroid and terpenoid which may be responsible 
for this therapeutic activity. Natural polyphenols have been 
reported to inhibit the activity of carbohydrate hydrolyzing 
enzymes like α-amylase, α-glucosidase[18]. Terpenoids 
represent a promising source for biologically active 
natural compounds which have potential for research and 
development of new substances with pharmacologic activity. 
α-Amylase inhibitory activity was related only for oleanane, 
ursane and lupane type terpenoids[20]. In a previous study 
saponins  have  also been found to be a probable α-amylase 
inhibitor[21,22]. Lupeol, a terpenoid compound has been 
isolated from stem bark of C. macroptera which could be 
α-amylase inhibitor[23]. There are previous findings about 
the potentiality of this compound. Lupeol have been shown 
to inhibit α-amylase reported by  Hasenah Ali, et al[24].  The 
mechanism by which this fruit extract exerted this effect 
may be due to its action on carbohydrate binding regions of 
α-amylase enzymes that catalyze hydrolysis of the internal 
α-1,4 glucosidic linkages in starch and other related 
polysaccharides have also been targeted for the suppression 
of postprandial hyperglycemia. Therefore, this study buttress 
the claim that natural inhibitors from dietary plants have 
α-amylase inhibitory activity and could be used as effective 
therapy for the management of postprandial hyperglycemia 
with minimal side effects.
4.2. In vivo hypoglycemic activity
   In this study methanolic fruit extract of C. macroptera 
exerted significant hypoglycemic activity in both fasting 
glucose level reduction in normal rats and oral glucose 
tolerance test in glucose induced hyperglycemic rats. To our 
best knowledge this is the first study about hypoglycemic 
activity of C. macroptera. That’s why the precise mode of 
action is not determined yet. However this fruit extract 
contains some potent phytochemical constituents like 
saponin, steroid and terpenoid which may be responsible 
for this action. Earlier investigations found saponins to be 
bioactive against diabetes[25,26]. Saponins can influence 
transport systems that are situated in the brush-border. 
For example, Sidhu, et al. gave rats soyabean saponins (2 g/L) 
directly into the small intestine and this led to a reduced 
glucose uptake[27]. Glycemic decrease that may also occur 
due to the stimulatory effect on beta cells to promote 
insulin release and intracellular glycogen deposition. Total 
saponins identified from traditional medicinal plant in China 
dramatically reduced fasted blood glucose and serum insulin 
levels and alleviated hyperglycemia associated oxidative 
stress in experimental type 2 DM rats[28]. Terpenoids 
identified in primary screening may contribute to this 
property. Terpenoids isolated from the some anti-diabetic 
medicinal plants has been found to stimulate secretion or 
possess an insulin like-effect[29]. Glycogen concentration 
is directly proportional to insulin level[30]. Insulin promotes 
intracellular glycogen deposition by stimulating glycogen 
synthesis and inhibiting glycogen phosphorylase[30]. Such 
as insulin, terpenoids type component or monoterpenes 
may cause a restoration to normal glycogen metabolism 
when hepatic glycogen concentration is decreased[31]. 
Lupeol and stigmasterol isolated from stem bark of C. 
macroptera may have hypoglycemic potential[23]. Lupeol 
is a pharmacologically active terpenoid. One study has 
also found some activity as a dipeptidyl peptidase-4 
inhibitor. Dipeptidyl peptidase-4 plays a major role in 
glucose metabolism. It is responsible for the degradation 
of incretins such as glucagon-like peptide-1[32]. Lupeol 
may also have amylase inhibition property which we told 
in previous section. We found the presence of steroid in 
phytochemical screening test which could also contribute 
to hypoglycemic action. In an earlier investigation Daisy, et 
al. isolated a novel steroid demonstrated a significant anti-
diabetic activity by reducing the elevated blood glucose 
levels and restoring the insulin levels in streptozotocin-
induced diabetic rats[33]. Stigmasterol, an steroid molecule, 
also possess hypoglycemic property[34]. Lemonene isolated 
from peel extract of C. macroptera may be a potential 
alternative[35]. In a previous study its anti-hyperglycemic 
activity has been confirmed in streptozotocin-induced 
diabetic rats by increasing glucokinase activity along with 
liver glycogen synthesis and decreasing plasma glucose and 
glycosylated hemoglobin levels[36]. Besides phytochemical 
constituents found in this extract may also have anti-
α-amylase activity (discussed in previous section) and 
contribute to this  in vivo hypoglycemic action.
   We are still not sure about how this fruit extract can exert 
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potent hypoglycemic activity. It is a logical inference that 
this extract may decrease the activity of α-amylase in the 
digestive canal, improve the metabolism of glucose and 
increase insulin secretion by stimulating beta cells. It is 
possibe to suggest that the bioactive compounds present in 
the fruit extract may be responsible for multifaceted effects. 
However further co-ordinated and well-structured studies 
would be required to isolate the bioactive compounds and 
determine their underlying molecular mechanism of action 
on diabetes induced rat model. 
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Comments 
Background
   C. macroptera is commonly called ‘wild orange’. It is so-
called name because of the large ‘wings’ (-ptera) on the 
petiole, which is as large as the blade of the leaf. The juice 
is very sour, and somewhat bitter. It has a unique taste and 
aroma. According to the literature search, there is no work 
that has been done on the fruit of this plant for hypoglycemic 
activity.
  
Research frontiers
   The hypoglycemic effect in OGTT and α-amylase 
inhibitory activity was evaluated. The results support 
significant activity of this fruit extract which was the cutting 
age in the field of the research in this paper.
Related reports
   Lupeol and stigmasterol were isolated from the crude 
extracts of the stem bark of C. macroptera (family: Rutaceae) 
by Chowdhury, et al (2008). The essential oil of C. macroptera 
Montr. contained limonene, beta-caryophyllene and 
geranial as main compounds reported by Rana, et al (2012). 
Traditionally this fruit is used as vegetable and curries 
cooked with Satkara and beef or mutton is now served in 
many restaurants in Bangladesh.
Innovations and breakthroughs
   This is the first research work on C. macroptera fruit 
for hypoglycemic effect. In future these findings will help 
researchers to find out potential antidiabetic agents in this 
plant.
  
Applications
   C. macroptera fruit is safe to eat. This study supports the 
claim that diabetes patients can eat this fruit because there 
is no restriction from physicians to take Citrus fruits. So this 
plant could be further studied for both drug development 
and establishment of the ethno medicinal use from this.
Peer review
   This research is an excellent piece of work where 
hypoglycemic effect of a fruit extract from C. macroptera 
observed and this is a unique work of this fruit in the world 
as far as I know. Author coherently discussed therapeutic 
properties of phytochemical constituents to support the 
hypoglycemic potential of the fruit extract. α-Amylase 
inhibition property and OGTT was performed for this research 
and the result was significant; also there was a set up of 
standard methodology.
References
[1]    Riaz S. Diabetes mellitus. Sci Res Essay 2009; 4(5): 367-373.
[2]    Groop L, Forsblom C, Lehtovirta M. Characterization of the 
prediabetic state. Am J Hypertens 1997; 10: 172S-180S.
[3]    Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-
diabetes potential. J Ethnopharmacol 2002; 81(1): 81-100.
[4]    Algariri K, Meng KY, Atangwho IJ, Asmawi MZ, Sadikun A, 
Murugaiyah V, et al. Hypoglycemic and anti-hyperglycemic 
study of Gynura procumbens leaf extracts. Asian Pac J Trop 
Biomed 2013; 3(5): 358-366.
[5]    Malviya N, Jain S, Malviya S. Antidiabetic potential of medicinal 
plants. Acta Pol Pharm 2010; 67(2): 113-118.
[6]    Peng CH, Ker YB, Weng CF, Peng CC, Huang CN, Lin LY, et 
al. Insulin secretagogue bioactivity of finger citron fruit (Citrus 
medica L. var. Sarcodactylis Hort, Rutaceae). J Agric Food Chem 
2009; 57(19): 8812-8819.
[7]    Li JM, Che CT, Lau CBS, Leung PS, Cheng CHK. Inhibition of 
intestinal and renal Na+-glucose cotransporter by naringenin. 
Int J Biochem Cell Biol 2006; 38: 985-995.
[8]    Kim GS, Shin JG, Jang HD. Antioxidant and antidiabetic activity 
Nizam Uddin et al./Asian Pac J Trop Biomed 2014; 4(6): 473-479 479
of Dangyuja (Citrus grandis Osbeck) extract treated with 
Aspergillus saitoi. Food Chem 2009; 117(1): 35-41.
[9]   Kundusen S, Haldar PK, Gupta M, Mazumder UK, Saha P, Bala 
A, et al. Evaluation of antihyperglycemic activity of Citrus 
limetta fruit peel in streptozotocin-induced diabetic rats. ISRN 
Endocrinol 2011;  doi: 10.5402/2011/869273.
[10]  Kujur RS, Singh V, Ram M, Yadava HN, Singh KK, Kumari S, et 
al. Antidiabetic activity and phytochemical screening of crude 
extract of Stevia rebaudiana in alloxan-induced diabetic rats. 
Pharmacogn Res 2010; 2(4): 258-263.
[11]  Hossan SJ, El-Sayed M, Aoshima H. Antioxidative and anti 
α-amylase activities of four wild plants consumed by nomads in 
Egypt. Orient Pharm Exp Med 2009; 9(3): 217-224.
[12]  Walum E. Acute oral toxicity. Environ Health Perspect 1998; 
106(Suppl 2): 497-503.
[13]  Barham D, Trinder P. An improved color reagent for the 
determination of blood glucose by oxidase system. Analyst 1972; 
97: 142-145.
[14]  Vigneaud DU, Karr WG.Carbohydrate utilization: I. rate of 
disappearance of d-glucose from the blood. J Biol Chem 1925; 
66: 281-300.
[15]  Ranilla LG, Kwon YI, Apostolidis E, Shetty K. Phenolic 
compounds, antioxidant activity and in vitro inhibitory potential 
against key enzymes relevant for hyperglycemia and hypertension 
of commonly used medicinal plants, herbs and spices in Latin 
America. Bioresour Technol 2010; 101(12): 4676-4689.
[16]  El-Kaissi S, Sherbeeni S. Pharmacological management of type 
2 diabetes mellitus: an update. Curr Diabetes Rev 2011; 7(6): 
392-405.
[17]  Barrett ML, Udani JK. A proprietary alpha-amylase inhibitor 
from white bean (Phaseolus vulgaris): a review of clinical studies 
on weight loss and glycemic control. Nutr J 2011; 10: 24.
[18]  Tundis R, Loizzo MR, Menichini F. Natural products as 
alpha-amylase and alpha-glucosidase inhibitors and their 
hypoglycemic potential in the treatment of diabetes: an update. 
Mini Rev Med Chem 2010; 10(4): 315-331.
[19]  Nair SS, Kavrekar V, Mishra A. In vitro studies on alpha amylase 
and alpha glucosidase inhibitory activities of selected plant 
extracts. Eur J Exp Biol 2013; 3(1): 128-132.
[20]  Sales PM, Souza PM, Simeoni LA, Silveira D. α-Amylase 
inhibitors: a review of raw material and isolated compounds from 
plant source. J Pharm Pharm Sci 2012; 15(1): 141-183.
[21]  Ponnusamy S, Ravindran R, Zinjarde S, Bhargava S, Ravi Kumar 
A. Evaluation of traditional Indian antidiabetic medicinal plants 
for human pancreatic amylase inhibitory effect in vitro. Evid 
Based Complement Alternat Med 2011; doi: 10.1155/2011/515647.
[22]  Sudha P, Zinjarde SS, Bhargava SY, Kumar AR. Potent α-amylase 
inhibitory activity of Indian ayurvedic medicinal plants. BMC 
Complement Altern Med 2011; doi: 10.1155/2011/515647.
[23]  Chowdhury SA, Sohrab MH, Datta BK, Hasan CM. Chemical and 
antioxidant studies of Citrus macroptera. Bangladesh J Sci Ind 
Res 2008; 43(4): 449-454.
[24]  Ali H, Houghton PJ, Soumyanath A. Alpha-amylase inhibitory 
activity of some Malaysian plants used to treat diabetes; with 
particular reference to Phyllanthus amarus. J Ethnopharmacol 
2006; 107(3): 449-455. 
[25]  Hamden K, Jaouadi B, Salami T, Carreau S, Bejar S, Elfeki A. 
Modulatory effect of fenugreek saponins on the activities of 
intestinal and hepatic disaccharidase and glycogen and liver 
function of diabetic rats. Biotechnol Bioprocess Eng 2010; 15(5): 
745-753.
[26]  Chen ZH, Li J, Liu J, Zhao Y, Zhang P, Zhang MX, et al. Saponins 
isolated from the root of Panax notoginseng showed significant 
anti-diabetic effects in KK-Ay mice. Am J Chin Med 2008; 36(5): 
939-951.
[27]  Sidhu GS, Upson B, Malinow MR. Effects of soy saponins and 
tigogenin cellobioside on intestinal uptake of cholesterol, cholate 
and glucose. Nutr Rep Int 1987; 35(3): 615-623.
[28]  Zheng T, Shu G, Yang Z, Mo S, Zhao Y, Mei Z. Antidiabetic effect 
of total saponins from Entada phaseoloides (L.) Merr. in type 2 
diabetic rats. J Ethnopharmacol 2012; 139(3): 814-821.
[29]  Goto T, Takahashi N, Hirai S, Kawada T. Various terpenoids 
derived from herbal and dietary plants function as PPAR 
modulators and regulate carbohydrate and lipid metabolism. 
PPAR Res 2010; doi: 10.1155/2010/483958.
[30]  Jensen J, Lai YC. Regulation of muscle glycogen synthase 
phosphorylation and kinetic properties by insulin, exercise, 
adrenaline and role in insulin resistance. Arch Physiol Biochem 
2009; 115(1): 13-21.
[31]  Muhammad NO, Soji-Omoniwa O, Usman LA, Omoniwa BP. 
Antihyperglycemic activity of leaf essential oil of Citrus sinensis 
(L.) Osbeck on alloxan-induced diabetic rats. Ann Rev Res Biol 
2013; 3(4): 825-334.
[32]  Marques MR, Stüker C, Kichik N, Tarragó T, Giralt E, Morel AF, 
et al. Flavonoids with prolyl oligopeptidase inhibitory activity 
isolated from Scutellaria racemosa Pers. Fitoterapia 2010; 81(6): 
552-556.
[33]  Daisy P, Jasmine R, Ignacimuthu S, Murugan E. A novel steroid 
from Elephantopus scaber L. an ethnomedicinal plant with 
antidiabetic activity. Phytomedicine 2009; 16: 252-257.
[34]  Panda S, Jafri M, Kar A, Meheta BK. Thyroid inhibitory, 
antiperoxidative and hypoglycemic effects of stigmasterol 
isolated from Butea monosperma. Fitoterapia 2009; 80(2): 123-126.
[35]  Rana VS, Blazquez MA. Compositions of the volatile oils of 
Citrus macroptera and C. maxima. Nat Prod Commun 2012; 7(10): 
1371-1372.
[36]  Murali R, Saravanan R. Antidiabetic effect of d-limonene, a 
monoterpene in streptozotocin-induced diabetic rats. Biomed 
Prev Nutri 2012; 2(4): 269-275.
